Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126499142 | 12649914 | 2 | F | 20150831 | 20160811 | 20160813 | 20160822 | EXP | FR-AMGEN-FRACT2016103347 | AMGEN | 0.00 | Y | 0.00000 | 20160822 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126499142 | 12649914 | 1 | PS | denosumab | DENOSUMAB | 1 | Unknown | UNK | 125320 | SOLUTION FOR INJECTION | |||||||||
| 126499142 | 12649914 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126499142 | 12649914 | 3 | SS | PEMETREXED | PEMETREXED | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126499142 | 12649914 | 1 | Non-small cell lung cancer |
| 126499142 | 12649914 | 2 | Non-small cell lung cancer |
| 126499142 | 12649914 | 3 | Non-small cell lung cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126499142 | 12649914 | HO |
| 126499142 | 12649914 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126499142 | 12649914 | Anaemia | |
| 126499142 | 12649914 | Aplasia | |
| 126499142 | 12649914 | General physical health deterioration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |